Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Aesthetic Medicine Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing adoption of minimally invasive treatments
3.3.1.2. Growing population aged between 25 and 65 years
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of reimbursement coverage
3.3.2.2. Stringent regulatory framework
3.4. Aesthetic Medicine: Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
3.4.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Aesthetic Medicine Market: Segment Analysis, By -Procedure Type, 2018 – 2030 (USD Million)
4.1. Definitions & Scope
4.2. Procedure type market share analysis, 2022 & 2030
4.3. Global Aesthetic Medicine Market, By Procedure Type, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Invasive procedures
4.4.1.1. Breast augmentation
4.4.1.2. Liposuction
4.4.1.3. Nose reshaping
4.4.1.4. Eyelid Surgery
4.4.1.5. Tummy tuck
4.4.1.6. Others
4.4.2. Non-invasive procedure
4.4.2.1. Botox injections
4.4.2.2. Soft tissue fillers
4.4.2.3. Chemical peel
4.4.2.4. Laser hair removal
4.4.2.5. Microdermabrasion
4.4.2.6. Others
Chapter 5. Aesthetic Medicine Market: Regional Market Analysis, By Region, 2018 – 2030 (USD Million)
5.1. Definitions & Scope
5.2. Regional market share analysis, 2022 & 2030
5.3. Regional Market Dashboard
5.4. Regional Market: Key Players
5.5. Market Size, & Forecasts, and Trend Analysis, 2021 to 2030:
5.6. North America
5.6.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
5.6.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.6.3. U.S.
5.6.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.6.4. Canada
5.6.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.7. Europe
5.7.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
5.7.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.7.3. Germany
5.7.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.7.4. UK
5.7.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.7.5. France
5.7.5.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.7.6. Italy
5.7.6.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.7.7. Spain
5.7.7.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.8. Asia Pacific
5.8.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
5.8.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.8.3. China
5.8.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.8.4. Japan
5.8.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.8.5. India
5.8.5.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.8.6. Australia
5.8.6.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.8.7. South Korea
5.8.7.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.9. Latin America
5.9.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
5.9.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.9.3. Brazil
5.9.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.9.4. Mexico
5.9.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.9.5. Argentina
5.9.5.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.10. Middle East and Africa
5.10.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
5.10.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.10.3. South Africa
5.10.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.10.4. Saudi Arabia
5.10.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
5.10.5. UAE
5.10.5.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
Chapter 6. Aesthetic Medicine Market – Competitive Analysis
6.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.3. Key companies profiled
6.3.1. Evolus, Inc.
6.3.1.1. Company Overview
6.3.1.2. Financial Performance
6.3.1.3. Product Benchmarking
6.3.1.4. Strategic Initiatives
6.3.2. Cynosure.
6.3.2.1. Company Overview
6.3.2.2. Financial Performance
6.3.2.3. Product Benchmarking
6.3.2.4. Strategic Initiatives
6.3.3. Revance Therapeutics, Inc.
6.3.3.1. Company Overview
6.3.3.2. Financial Performance
6.3.3.3. Product Benchmarking
6.3.3.4. Strategic Initiatives
6.3.4. Galderma S.A.
6.3.4.1. Company Overview
6.3.4.2. Financial Performance
6.3.4.3. Product Benchmarking
6.3.4.4. Strategic Initiatives
6.3.5. Alma Lasers
6.3.5.1. Company Overview
6.3.5.2. Financial Performance
6.3.5.3. Product Benchmarking
6.3.5.4. Strategic Initiatives
6.3.6. AbbVie
6.3.6.1. Company Overview
6.3.6.2. Financial Performance
6.3.6.3. Product Benchmarking
6.3.6.4. Strategic Initiatives
6.3.7. Solta Medical
6.3.7.1. Company Overview
6.3.7.2. Financial Performance
6.3.7.3. Product Benchmarking
6.3.7.4. Strategic Initiatives
6.3.8. Lumenis
6.3.8.1. Company Overview
6.3.8.2. Financial Performance
6.3.8.3. Product Benchmarking
6.3.8.4. Strategic Initiatives
6.3.9. Syneron Candela
6.3.9.1. Company Overview
6.3.9.2. Financial Performance
6.3.9.3. Product Benchmarking
6.3.9.4. Strategic Initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/